ArticleGland surgery2025
Oncological characteristics predict permanent hypoparathyroidism following total thyroidectomy for papillary thyroid carcinoma: a study from China.
Article in Gland surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Detection of preoperative serum trace elements in thyroid tumors.Gland surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Papillary thyroid carcinoma (PTC) is the most common endocrine malignancy, and total thyroidectomy is frequently recommended for patients with bilateral disease, large tumors, extrathyroidal extension (ETE), or lymph node metastasis. Hypoparathyroidism is one of the most clinically significant complications after total thyroidectomy, resulting from inadvertent parathyroid gland (PG) injury, devascularization, or removal. Permanent hypoparathyroidism can lead to chronic hypocalcemia, neuromuscular symptoms, renal impairment, and impaired quality of life. While many studies have investigated risk factors for hypoparathyroidism in general thyroidectomy populations, few have focused specifically on oncological characteristics that predict permanent hypoparathyroidism among PTC patients. This study aimed to evaluate oncological predictors of permanent hypoparathyroidism following total thyroidectomy for PTC in a Chinese population. Methods: A retrospective cohort study was conducted, including 367 patients with postoperative histological confirmation of PTC who underwent total thyroidectomy at a tertiary center in China between January 2017 and January 2021. Clinical, surgical, and pathological parameters were collected. Hypoparathyroidism was defined as low serum calcium with suppressed parathyroid hormone (PTH), and permanent hypoparathyroidism was defined as persistence beyond 6 months. Univariate analyses were performed to screen potential risk factors, and variables with P<0.1 were included in multivariate logistic regression to identify independent predictors. Results: Permanent hypoparathyroidism developed in 27 patients (7.36%). In univariate analysis, ETE, tumor size, number of involved central lymph nodes (CLNs), and presence of parathyroid tissue in pathological specimens were associated with permanent hypoparathyroidism. Multivariate logistic regression demonstrated three independent predictors: gross ETE [odds ratio (OR) =3.584, P=0.02], presence of parathyroid tissue in pathological specimens (OR =3.809, P=0.005), and a higher number of involved CLNs (OR =1.147, P=0.049). These findings suggest that tumor aggressiveness and surgical complexity contribute to long-term parathyroid dysfunction. Conclusions: Tumor invasiveness and surgical-related factors significantly contribute to the risk of permanent hypoparathyroidism after total thyroidectomy in PTC patients. Particular attention should be paid to preserving PGs during extensive resection in cases of gross ETE and heavy CLN involvement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.